BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2488236)

  • 1. Tumor progression stage: specific losses of heterozygosity.
    Cavenee WK
    Princess Takamatsu Symp; 1989; 20():33-42. PubMed ID: 2488236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitotic abnormalities leading to cancer predisposition and progression.
    Cavenee WK
    Cancer Detect Prev; 1989; 14(2):269-73. PubMed ID: 2559800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accumulation of genetic defects during astrocytoma progression.
    Cavenee WK
    Cancer; 1992 Sep; 70(6 Suppl):1788-93. PubMed ID: 1325281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetics of human cancer predisposition and progression.
    Cavenee WK; Scrable HJ; James CD
    Mutat Res; 1991 Apr; 247(2):199-202. PubMed ID: 2011137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal genomic alterations in glioma malignancy stages.
    James CD; Carlbom E; Dumanski JP; Hansen M; Nordenskjold M; Collins VP; Cavenee WK
    Cancer Res; 1988 Oct; 48(19):5546-51. PubMed ID: 2901288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis.
    Shen CY; Yu JC; Lo YL; Kuo CH; Yue CT; Jou YS; Huang CS; Lung JC; Wu CW
    Cancer Res; 2000 Jul; 60(14):3884-92. PubMed ID: 10919664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosomal mechanisms in the initiation of human familial mixed cancers.
    Cavenee WK
    Princess Takamatsu Symp; 1986; 17():171-9. PubMed ID: 3332009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression.
    Rempel SA; Schwechheimer K; Davis RL; Cavenee WK; Rosenblum ML
    Cancer Res; 1993 May; 53(10 Suppl):2386-92. PubMed ID: 8485725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tumor suppressor genes].
    Kohno T; Yokota J
    Gan To Kagaku Ryoho; 1993 Jul; 20(9):1265-73. PubMed ID: 8392829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
    Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
    Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel genomic markers related to progression to glioblastoma through genomic profiling of 25 primary glioma cell lines.
    Roversi G; Pfundt R; Moroni RF; Magnani I; van Reijmersdal S; Pollo B; Straatman H; Larizza L; Schoenmakers EF
    Oncogene; 2006 Mar; 25(10):1571-83. PubMed ID: 16247447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic events unmask recessive cancer genes to initiate malignancy.
    Gallie BL; Worton RG
    J Cell Biochem; 1986; 32(3):215-22. PubMed ID: 3023409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple genetic alterations in small-cell lung carcinoma.
    Yokota J; Mori N; Akiyama T; Shimosato Y; Sugimura T; Terada M
    Princess Takamatsu Symp; 1989; 20():43-8. PubMed ID: 2577337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low incidence of loss of chromosome 10 in sporadic and hereditary human medullary thyroid carcinoma.
    Nelkin BD; Nakamura Y; White RW; de Bustros AC; Herman J; Wells SA; Baylin SB
    Cancer Res; 1989 Aug; 49(15):4114-9. PubMed ID: 2568166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of bacterial artificial chromosome array-based comparative genomic hybridization and spectral karyotyping to the analysis of glioblastoma multiforme.
    Cowell JK; Matsui S; Wang YD; LaDuca J; Conroy J; McQuaid D; Nowak NJ
    Cancer Genet Cytogenet; 2004 May; 151(1):36-51. PubMed ID: 15120909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current knowledge of heritable tumors.
    Cavenee WK
    Birth Defects Orig Artic Ser; 1989; 25(2):29-43. PubMed ID: 2655740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
    Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
    Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gliomas.
    Collins VP
    Cancer Surv; 1998; 32():37-51. PubMed ID: 10489622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tumor suppressor genes. New perspectives for clinical investigations in cancer].
    Paván J; Gualandi F; Rimessi P; Corallini A; Barbanti-Brodano G
    Medicina (B Aires); 1994; 54(2):163-8. PubMed ID: 7997135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and functional evidence for the presence of tumor suppressor genes on the short arm of chromosome 10 in human gliomas.
    Kon H; Sonoda Y; Kumabe T; Yoshimoto T; Sekiya T; Murakami Y
    Oncogene; 1998 Jan; 16(2):257-63. PubMed ID: 9464544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.